Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false answering member label
creator	label
publisher	pref label
tabling member	label

Search

63468

	human indexable
	published
	registered interest
	answer date	26/06/2014
	date	24/06/2014
	date tabled	24/06/2014
	ddp created	24/06/2014 20:30:36
	ddp modified	07/02/2015 11:10:33
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	NHS: Drugs
	house id	1
	identifier	202107
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	01/07/2014 14:35:50
	question text	To ask the Secretary of State for Business, Innovation and Skills, what assessment he has made of the effect of the US-EU Transatlantic Trade and Investment Partnership on the cost of medicine procurement for the NHS.
	session	2014/15
	session number	4
	tabling member constituency	Carmarthen East and Dinefwr
	tabling member printed	Jonathan Edwards
	title	House of Commons Tabled Parliamentary Question 2014/15 202107
	type	WrittenParliamentaryQuestion
	uin	202107
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 88 label Biography information for Sir Michael Fallon
	creator	3943 label Biography information for Jonathan Edwards
	publisher	25259 pref label House of Commons
	tabling member	3943 label Biography information for Jonathan Edwards

540147

	human indexable
	published
	registered interest
	answer date	21/07/2016
	date	19/07/2016
	date tabled	19/07/2016
	ddp created	19/07/2016 20:32:57
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	19/07/2016 20:39:29 28/07/2016 12:57:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	43441
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	28/07/2016 12:25:09
	question text	To ask the Secretary of State for Exiting the European Union, what his policy is on future UK involvement in the Innovative Medicines Initiative.
	session	2016/17
	session number	2
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2016/17 43441
	type	WrittenParliamentaryQuestion
	uin	43441
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 373 label Biography information for Sir David Davis
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259 pref label House of Commons
	tabling member	1533 label Biography information for Dame Diana Johnson

830233

	human indexable
	published
	registered interest
	answer date	29/01/2018
	date	24/01/2018
	date tabled	24/01/2018
	ddp created	24/01/2018 22:00:50
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	26/01/2018 14:05:23 01/02/2018 14:13:08
	hansard heading	NHS: Drugs
	house id	1
	identifier	124894
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	01/02/2018 13:41:13
	question text	To ask the Secretary of State for Exiting the European Union, with reference to the speech made by the Secretary of State for International Trade to the American Enterprise Institute of 24 July 2017, what assessment the Government has made of the effect of the increase in non-tariff barriers to trade between 2010 and 2015 on the UK pharmaceutical industry after the UK leaves the EU.
	session	2017/19
	session number	1
	tabling member constituency	Eddisbury
	tabling member printed	Antoinette Sandbach
	title	House of Commons Tabled Parliamentary Question 2017/19 124894
	type	WrittenParliamentaryQuestion
	uin	124894
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 4091 label Biography information for Mr Robin Walker
	creator	4506 label Biography information for Antoinette Sandbach
	publisher	25259 pref label House of Commons
	tabling member	4506 label Biography information for Antoinette Sandbach

946902

	human indexable
	published
	registered interest
	answer date	04/09/2018
	date	23/07/2018
	date tabled	23/07/2018
	ddp created	23/07/2018 21:53:13
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	23/07/2018 22:05:52 14/09/2018 10:32:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	167159
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	14/09/2018 10:01:10
	question text	To ask the Secretary of State for Exiting the European Union, what steps he has taken in negotiations on the UK leaving the EU to promote mutual access to medicines and drugs.
	session	2017/19
	session number	1
	tabling member constituency	Belfast North
	tabling member printed	Nigel Dodds
	title	House of Commons Tabled Parliamentary Question 2017/19 167159
	type	WrittenParliamentaryQuestion
	uin	167159
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 4091 label Biography information for Mr Robin Walker
	creator	1388 label Biography information for Lord Dodds of Duncairn
	publisher	25259 pref label House of Commons
	tabling member	1388 label Biography information for Lord Dodds of Duncairn

100977

	human indexable
	published
	registered interest
	answer date	10/11/2014
	date	27/10/2014
	date tabled	27/10/2014
	ddp created	27/10/2014 23:21:27
	ddp modified	06/02/2015 19:19:46
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	2
	identifier	HL2433
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	10/11/2014 14:29:40
	question text	To ask Her Majesty’s Government what safeguards exist to ensure that the pricing of "specials" drugs prescribed within the National Health Service is consistent and non-discriminatory, including when prescribed by general practitioners.
	session	2014/15
	session number	4
	tabling member printed	Lord Lester of Herne Hill
	title	House of Lords Tabled Parliamentary Question 2014/15 HL2433
	type	WrittenParliamentaryQuestion
	uin	HL2433
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 2000 label Biography information for Earl Howe
	creator	2037 label Biography information for Lord Lester of Herne Hill
	publisher	25277 pref label House of Lords
	tabling member	2037 label Biography information for Lord Lester of Herne Hill

114826

	human indexable
	published
	registered interest
	answer date	10/11/2014
	date	05/11/2014
	date tabled	05/11/2014
	ddp created	05/11/2014 23:16:04
	ddp modified	08/02/2015 07:14:15
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	identifier	213574
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	10/11/2014 12:01:27
	question text	To ask the Secretary of State for Health, how many times he has exercised his powers under the National Institute for Health and Care Excellence (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013 to refer an unlicensed indication of a drug for a NICE technology appraisal.
	session	2014/15
	session number	4
	tabling member constituency	Cambridge
	tabling member printed	Dr Julian Huppert
	title	House of Commons Tabled Parliamentary Question 2014/15 213574
	type	WrittenParliamentaryQuestion
	uin	213574
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction answering member 4020 label Biography information for George Freeman
	creator	3931 label Biography information for Dr Julian Huppert
	publisher	25259 pref label House of Commons
	tabling member	3931 label Biography information for Dr Julian Huppert

143398

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	07/11/2014
	date tabled	07/11/2014
	ddp created	07/11/2014 18:11:49
	ddp modified	08/02/2015 07:44:11
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	identifier	213834
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	17/11/2014 11:14:36
	question text	To ask the Secretary of State for Health, if he will issue a direction under Regulation 7 of the National Institue for Health and Care Excellence (NICE) (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013 to exempt clinical commissioning groups from the requirement to comply with NICE Technology Assessment Guidance TA155, in order that NHS commissioners can make their own decision on whether to issue the drug Avastin and Lucentis.
	session	2014/15
	session number	4
	tabling member constituency	West Bromwich East
	tabling member printed	Mr Tom Watson
	title	House of Commons Tabled Parliamentary Question 2014/15 213834
	type	WrittenParliamentaryQuestion
	uin	213834
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction answering member 4020 label Biography information for George Freeman
	creator	1463 label Biography information for Lord Watson of Wyre Forest
	publisher	25259 pref label House of Commons
	tabling member	1463 label Biography information for Lord Watson of Wyre Forest

166019

	human indexable
	published
	registered interest
	answer date	27/11/2014
	date	25/11/2014
	date tabled	25/11/2014
	ddp created	25/11/2014 23:03:20
	ddp modified	08/02/2015 11:40:57
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	identifier	215834
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	02/12/2014 14:07:57
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS provides fair access for all to life-extending drugs; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Blaydon
	tabling member printed	Mr David Anderson
	title	House of Commons Tabled Parliamentary Question 2014/15 215834
	type	WrittenParliamentaryQuestion
	uin	215834
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 4020 label Biography information for George Freeman
	creator	1486 label Biography information for Mr David Anderson
	publisher	25259 pref label House of Commons
	tabling member	1486 label Biography information for Mr David Anderson

175109

	human indexable
	published
	registered interest
	answer date	29/01/2015
	date	21/01/2015
	date tabled	21/01/2015
	ddp created	22/01/2015 00:12:27
	ddp modified	08/02/2015 23:45:05
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	identifier	221615
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	29/01/2015 10:27:54
	question text	To ask the Secretary of State for Health, how much the NHS spent on (a) all drugs, (b) cancer drugs and (c) drugs funded through the Cancer Drug Fund in each of the last five years for which figures are available.
	session	2014/15
	session number	4
	tabling member constituency	Chelmsford
	tabling member printed	Mr Simon Burns
	title	House of Commons Tabled Parliamentary Question 2014/15 221615
	type	WrittenParliamentaryQuestion
	uin	221615
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction answering member 4020 label Biography information for George Freeman
	creator	46 label Biography information for Sir Simon Burns
	publisher	25259 pref label House of Commons
	tabling member	46 label Biography information for Sir Simon Burns

179170

	human indexable
	published
	registered interest
	answer date	23/02/2015
	date	11/02/2015
	date tabled	11/02/2015
	ddp created	11/02/2015 23:35:55
	ddp modified	23/02/2015 16:48:07
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Drugs
	house id	1
	identifier	224200
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	23/02/2015 16:16:08
	question text	To ask the Secretary of State for Health, whether his Department has conducted a study on the viability of a New Medicines Fund for England.
	session	2014/15
	session number	4
	tabling member constituency	Brigg and Goole
	tabling member printed	Andrew Percy
	title	House of Commons Tabled Parliamentary Question 2014/15 224200
	type	WrittenParliamentaryQuestion
	uin	224200
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction answering member 4020 label Biography information for George Freeman
	creator	3939 label Biography information for Andrew Percy
	publisher	25259 pref label House of Commons
	tabling member	3939 label Biography information for Andrew Percy